Table 1.

Characteristics of patients with myasthenia gravis (MG).

Patient ID	Age	Degree of thymic hyperplasia	MGFA score at thymectomy	Corticoid treatment	Cholinesterase inhibitors	Anti-AChR titer (nmol/L)
MG1	33	NS	NS	No	No	2.48
MG2	27	Low	II b	No	Yes	1.67
MG3	39	Low	II b	No	Yes	1.82
MG4	19	High	II b	No	Yes	>100
MG5	35	High	NS	No	Yes	23.3
MG6	25	Low	II b	No	Yes	2.31
MG7	26	High	II b	No	Yes	5.7
MG8	34	Low	II b	No	Yes	1.04
MG9	32	NS	III b	No	Yes	NS
MG10	37	High	NS	No	Yes	5.82
MG11	27	Low	II b	No	Yes	1.64
MG12	33	Low	NS	No	Yes	12.3
MG13	28	Low	NS	No	Yes	117.8
MG14	19	NS	NS	No	No	>100
MG15	33	Low	NS	No	Yes	1.82
MG16	21	High	NS	No	Yes	29.1
MG17	36	NS	NS	No	No	>100
MG18	32	Low	NS	No	Yes	1.2
MG19	31	Low	NS	No	No	4.8
MG20	20	Low	NS	No	Yes	2.2
MG21	29	Low	NS	No	Yes	117.9
MG22	31	High	III b	No	Yes	65.8
MG23	38	Low	II a	No	Yes	>100
MG24	20	High	NS	No	Yes	10.9
MG25	35	High	NS	No	Yes	8.1
MG26	27	Low	NS	No	Yes	12.5
MG27	32	Low	NS	No	Yes	7.1
MG28	36	Low	II b	No	Yes	48.1
MG29	23	Low	II a	No	Yes	1.6
MG30	26	NS	NS	No	No	>100

MGFA, Myasthenia Gravis Foundation of America; AChR, acetylcholine receptor; NS, not specified.